ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

NVAX Novavax Inc

15.15
0.00 (0.00%)
May 23 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 15.09
Ask Price 15.13
News -
Day High

Low
3.5324

52 Week Range

High
17.40

Day Low
Company Name Stock Ticker Symbol Market Type
Novavax Inc NVAX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 15.15 20:00:00
Open Price Low Price High Price Close Price Prev Close
15.15
Trades Volume Avg Volume 52 Week Range
0 0 - 3.5324 - 17.40
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 15.15 USD

Novavax (NVAX) Options Flow Summary

Overall Flow

Bullish

Net Premium

3M

Calls / Puts

1,625.00%

Buys / Sells

63.41%

OTM / ITM

64.29%

Sweeps Ratio

0.00%

Novavax Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.12B 139.95M - 983.71M -545.06M -3.89 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Novavax News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NVAX Message Board. Create One! See More Posts on NVAX Message Board See More Message Board Posts

Historical NVAX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week14.3417.4012.6814.9118,578,7640.815.65%
1 Month3.9717.403.9211.4926,834,88811.18281.61%
3 Months5.0917.403.819.7212,427,07210.06197.64%
6 Months5.4717.403.53247.5210,665,4919.68176.97%
1 Year8.3017.403.53247.609,297,1756.8582.53%
3 Years144.34277.79993.532447.826,967,597-129.19-89.50%
5 Years6.14331.53883.532458.876,036,5909.01146.74%

Novavax Description

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population.

Your Recent History

Delayed Upgrade Clock